Market Closed -
Nasdaq
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
20.76
USD
|
+0.92%
|
|
+4.85%
|
+5.11%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
586.7
|
972.3
|
661.7
|
267.1
|
576.5
|
612.8
|
-
|
-
|
Enterprise Value (EV)
1 |
822.5
|
972.3
|
661.7
|
267.1
|
576.5
|
612.8
|
612.8
|
612.8
|
P/E ratio
|
-49.1
x
|
-12.2
x
|
-39.8
x
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.83
x
|
1.25
x
|
0.71
x
|
0.29
x
|
0.52
x
|
0.53
x
|
0.5
x
|
0.47
x
|
EV / Revenue
|
0.83
x
|
1.25
x
|
0.71
x
|
0.29
x
|
0.52
x
|
0.53
x
|
0.5
x
|
0.47
x
|
EV / EBITDA
|
9.67
x
|
14.3
x
|
7.12
x
|
3.44
x
|
5.51
x
|
5.31
x
|
4.93
x
|
4.35
x
|
EV / FCF
|
55.6
x
|
-
|
-
|
-
|
10.9
x
|
8.63
x
|
8.28
x
|
7.76
x
|
FCF Yield
|
1.8%
|
-
|
-
|
-
|
9.15%
|
11.6%
|
12.1%
|
12.9%
|
Price to Book
|
-
|
-
|
2.67
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
23,420
|
25,286
|
29,135
|
28,973
|
29,188
|
29,520
|
-
|
-
|
Reference price
2 |
25.05
|
38.45
|
22.71
|
9.220
|
19.75
|
20.76
|
20.76
|
20.76
|
Announcement Date
|
3/10/20
|
2/25/21
|
3/1/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
709.4
|
780.1
|
932.5
|
921.5
|
1,102
|
1,159
|
1,223
|
1,314
|
EBITDA
1 |
60.68
|
67.79
|
92.89
|
77.69
|
104.7
|
115.5
|
124.4
|
140.8
|
EBIT
1 |
45.54
|
42.9
|
56.19
|
45.09
|
60.14
|
78.56
|
88.73
|
109
|
Operating Margin
|
6.42%
|
5.5%
|
6.03%
|
4.89%
|
5.46%
|
6.78%
|
7.25%
|
8.3%
|
Earnings before Tax (EBT)
1 |
-17.61
|
-28.81
|
-12.51
|
-
|
2.366
|
36.86
|
44.63
|
-
|
Net income
1 |
-11.45
|
-77.47
|
-15.97
|
-
|
2.131
|
37.61
|
46.86
|
-
|
Net margin
|
-1.61%
|
-9.93%
|
-1.71%
|
-
|
0.19%
|
3.24%
|
3.83%
|
-
|
EPS
|
-0.5100
|
-3.150
|
-0.5700
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
10.56
|
-
|
-
|
-
|
52.74
|
71
|
74
|
79
|
FCF margin
|
1.49%
|
-
|
-
|
-
|
4.79%
|
6.12%
|
6.05%
|
6.01%
|
FCF Conversion (EBITDA)
|
17.4%
|
-
|
-
|
-
|
50.37%
|
61.47%
|
59.49%
|
56.11%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
2,474.99%
|
188.78%
|
157.9%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/10/20
|
2/25/21
|
3/1/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
196.6
|
275.7
|
252
|
209.7
|
184.1
|
290.5
|
314.5
|
277
|
219.9
|
308.4
|
330.1
|
288.7
|
232.1
|
323.5
|
348.2
|
EBITDA
1 |
15.31
|
31.6
|
27.58
|
19.21
|
12.88
|
30.72
|
32.87
|
29.28
|
12
|
35.26
|
34.87
|
29.09
|
16.25
|
38.53
|
36.06
|
EBIT
1 |
5.707
|
23.39
|
19.59
|
11.75
|
4.655
|
22.94
|
22.23
|
13.88
|
1.255
|
27.57
|
25.54
|
20.12
|
6.56
|
28.82
|
26.34
|
Operating Margin
|
2.9%
|
8.48%
|
7.77%
|
5.6%
|
2.53%
|
7.9%
|
7.07%
|
5.01%
|
0.57%
|
8.94%
|
7.74%
|
6.97%
|
2.83%
|
8.91%
|
7.56%
|
Earnings before Tax (EBT)
1 |
-
|
3.281
|
-
|
-
|
-
|
-
|
-
|
0.739
|
-18.35
|
15.35
|
15.52
|
10.62
|
-4.628
|
19.26
|
15.4
|
Net income
1 |
-14.12
|
3.131
|
-
|
-
|
-
|
-
|
-
|
0.451
|
-17.49
|
14.91
|
16.3
|
11.15
|
-4.859
|
20.22
|
16.17
|
Net margin
|
-7.18%
|
1.14%
|
-
|
-
|
-
|
-
|
-
|
0.16%
|
-7.95%
|
4.83%
|
4.94%
|
3.86%
|
-2.09%
|
6.25%
|
4.64%
|
EPS
|
-0.4900
|
0.1100
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/22
|
5/4/22
|
8/9/22
|
11/9/22
|
2/28/23
|
5/9/23
|
8/8/23
|
11/7/23
|
2/28/24
|
5/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
236
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.888
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
10.6
|
-
|
-
|
-
|
52.7
|
71
|
74
|
79
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-6.75%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-2.01%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
795.6
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
8.520
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
10.3
|
22.4
|
31.3
|
12
|
9.15
|
9
|
12
|
13
|
Capex / Sales
|
1.45%
|
2.87%
|
3.35%
|
1.3%
|
0.83%
|
0.78%
|
0.98%
|
0.99%
|
Announcement Date
|
3/10/20
|
2/25/21
|
3/1/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
20.76
USD Average target price
29.33
USD Spread / Average Target +41.30% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.11% | 613M | | -14.09% | 77.37B | | +18.66% | 8.74B | | +23.75% | 3.67B | | -0.42% | 3.25B | | +18.07% | 1.73B | | -16.99% | 1.38B | | -26.05% | 1.24B | | -17.86% | 1.07B | | -6.77% | 976M |
Veterinary Drugs
|